140 related articles for article (PubMed ID: 12757720)
1. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary evaluation of [18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo.
Zhang MR; Tsuchiyama A; Haradahira T; Furutsuka K; Yoshida Y; Kida T; Noguchi J; Irie T; Suzuki K
Nucl Med Biol; 2002 May; 29(4):463-8. PubMed ID: 12031881
[TBL] [Abstract][Full Text] [Related]
3. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
4. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4'-fluorobenzoate and their biodistribution in mice.
Bormans G; Sherman P; Snyder SE; Kilbourn MR
Nucl Med Biol; 1996 May; 23(4):513-7. PubMed ID: 8832709
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 5,7-dihydro-3-[2-[1-(4-[18F]-fluorobenzyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one for in vivo mapping of acetylcholinesterase.
Lee SY; Choe YS; Kim YR; Paik JY; Choi BW; Kim SE; Lee KH; Choi Y; Kim BT
Nucl Med Commun; 2004 Jun; 25(6):591-6. PubMed ID: 15167519
[TBL] [Abstract][Full Text] [Related]
9. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.
Yui J; Maeda J; Kumata K; Kawamura K; Yanamoto K; Hatori A; Yamasaki T; Nengaki N; Higuchi M; Zhang MR
J Nucl Med; 2010 Aug; 51(8):1301-9. PubMed ID: 20660373
[TBL] [Abstract][Full Text] [Related]
10. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain.
Zhang MR; Maeda J; Ogawa M; Noguchi J; Ito T; Yoshida Y; Okauchi T; Obayashi S; Suhara T; Suzuki K
J Med Chem; 2004 Apr; 47(9):2228-35. PubMed ID: 15084121
[TBL] [Abstract][Full Text] [Related]
11. Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers.
Ohya T; Okamura T; Nagai Y; Fukushi K; Irie T; Suhara T; Zhang MR; Fukumura T; Kikuchi T
Neuroimage; 2011 Jun; 56(3):1105-10. PubMed ID: 21324368
[TBL] [Abstract][Full Text] [Related]
12. Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies.
Kim DH; Choe YS; Choi JY; Lee KH; Kim BT
Nucl Med Biol; 2011 May; 38(4):541-7. PubMed ID: 21531291
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers.
Shao X; Koeppe RA; Butch ER; Kilbourn MR; Snyder SE
Bioorg Med Chem; 2005 Feb; 13(3):869-75. PubMed ID: 15653352
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).
Kilbourn MR; Snyder SE; Sherman PS; Kuhl DE
Synapse; 1996 Feb; 22(2):123-31. PubMed ID: 8787128
[TBL] [Abstract][Full Text] [Related]
16. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
17. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
18. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
[TBL] [Abstract][Full Text] [Related]
19. The position of fluorine in CP-118,954 affects AChE inhibition potency and PET imaging quantification for AChE expression in the rat brain.
Lee BC; Moon BS; Park HS; Jung JH; Park HS; Park DD; de Candia M; Denora N; Altomare CD; Kim SE
Eur J Pharm Sci; 2017 Nov; 109():209-216. PubMed ID: 28818531
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
